VANDA PHARMACEUTICALS INC. Debt Securities, Available-for-sale
VANDA PHARMACEUTICALS INC. (VNDA) had Debt Securities, Available-for-sale of $382.63 million as of 2022-06-30, per its 10-Q filed 2022-08-04.
Discontinued › Balance Sheet › Assets
us-gaap:AvailableForSaleSecuritiesDebtSecurities · last filed 2022-08-04
- 2022-06-30: Debt Securities, Available-for-sale $382.63M.
- 2022-03-31: Debt Securities, Available-for-sale $368.25M.
- 2021-12-31: Debt Securities, Available-for-sale $380.74M.
- 2021-09-30: Debt Securities, Available-for-sale $355.45M.
| Period end | Debt Securities, Available-for-sale |
|---|---|
| 2022-06-30 | $382.63M 10-Q · filed 2022-08-04 |
| 2022-03-31 | $368.25M 10-Q · filed 2022-05-06 |
| 2021-12-31 | $380.74M 10-Q · filed 2022-08-04 |
| 2021-09-30 | $355.45M 10-Q · filed 2021-11-04 |
| 2021-06-30 | $339.25M 10-Q · filed 2021-07-29 |
| 2021-03-31 | $306.03M 10-Q · filed 2021-05-06 |
| 2020-12-31 | $306.71M 10-K · filed 2022-02-24 |
| 2020-09-30 | $291.57M 10-Q · filed 2020-10-29 |
| 2020-06-30 | $244.54M 10-Q · filed 2020-08-06 |
| 2019-12-31 | $267.06M 10-K · filed 2021-02-11 |
| 2019-09-30 | $260.40M 10-Q · filed 2019-11-07 |
| 2019-06-30 | $246.13M 10-Q · filed 2019-08-01 |
| 2012-06-30 | $50.31M 10-Q · filed 2012-08-03 |
| 2011-12-31 | $60.96M 10-Q · filed 2012-08-03 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| STANDARD BIOTOOLS INC. (LAB) | United States | $0.297B | 3.80 |
| ROCKET PHARMACEUTICALS, INC. (RCKT) | United States | $0.296B | -21.78 |
| GT Biopharma, Inc. (GTBP) | United States | $0.309B | -4.58 |
| ABEONA THERAPEUTICS INC. (ABEO) | United States | $0.312B | -5.63 |
| Fulcrum Therapeutics, Inc. (FULC) | United States | $0.289B | -3.28 |
| Contineum Therapeutics, Inc. (CTNM) | United States | $0.289B | -4.40 |
| Prelude Therapeutics Inc (PRLD) | United States | $0.318B | -7.01 |
| Perspective Therapeutics, Inc. (CATX) | United States | $0.284B | -3.34 |
| Evommune, Inc. (EVMN) | United States | $0.320B | -5.10 |
| Upstream Bio, Inc. (UPB) | United States | $0.284B | -2.42 |